Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-10

Clinical Trial Update: The Use of Guarana to Treat Fatigue in Patients With Neuroendocrine Tumors and Gynecologic Cancers (Guarana Fatigue) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating guarana for fatigue in patients with neuroendocrine tumors and gynecologic cancers is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Guarana

Snippet

Sponsor: University of Utah | Conditions: Neuroendocrine Tumors, Gynecologic Cancer | Phase 2 | Status: RECRUITING